Katherine Soine
Psychiatric/Mental Health · Ponte Vedra, FLNPI 1255096343
Payments from drug & device makers
Across 372 payments — averaging $21.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$870
- Vanda Pharmaceuticals Inc.$602
- Neurocrine Biosciences, Inc.$548
- Axsome Therapeutics, Inc.$508
- plus $3K from 13 others
What the payments were for
- Food & beverage$7,89799%
- Education$1201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 100 | $1,481 |
| Otsuka America Pharmaceutical, Inc. | 46 | $1,221 |
| AbbVie | 29 | $870 |
| Vanda Pharmaceuticals Inc. | 28 | $602 |
| Neurocrine Biosciences, Inc. | 28 | $548 |
| Axsome Therapeutics, Inc. | 18 | $508 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $486 |
| Johnson & Johnson | 18 | $413 |
| Lundbeck LLC | 17 | $409 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $385 |
| Alkermes, Inc. | 13 | $307 |
| Almatica Pharma LLC | 13 | $296 |
| Bausch Health US, LLC | 7 | $132 |
| E.r. Squibb & Sons, L.L.C. | 6 | $122 |
| Idorsia Pharmaceuticals US Inc | 6 | $107 |
| Neos Therapeutics, LP | 3 | $53 |
| Indivior Inc. | 2 | $40 |
| Tris Pharma Inc | 1 | $19 |
| Merck | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$251
- REXULTI$236
- ABILIFY ASIMTUFII$123
- ABILIFY MAINTENA$123
- Auvelity$122
How this compares
$8,017 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 28 | $253,946 |
| IngrezzaValbenazine Tosylate | 19 | $159,325 |
| AustedoDeutetrabenazine | 15 | $147,967 |
| VraylarCariprazine Hcl | 100 | $132,826 |
| Invega SustennaPaliperidone Palmitate | 11 | $44,216 |
| RexultiBrexpiprazole | 16 | $23,355 |
| CaplytaLumateperone Tosylate | 13 | $20,258 |
| BelsomraSuvorexant | 33 | $13,864 |
| Olanzapine | 40 | $9,204 |
| Bupropion XlBupropion Hcl | 175 | $6,027 |
| Lurasidone Hcl | 24 | $5,762 |
| VyvanseLisdexamfetamine Dimesylate | 14 | $5,284 |
| Aripiprazole | 74 | $4,424 |
| Quetiapine Fumarate | 205 | $3,477 |
| Fluphenazine Hcl | 18 | $2,578 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr, Austedo | $1,481 | $401,91243 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $548 | $159,32519 claims |
| AbbVieVraylar | $870 | $132,826100 claims |
| Johnson & JohnsonInvega Sustenna | $413 | $44,21611 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,221 | $23,35516 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $486 | $20,25813 claims |
| MerckBelsomra | $17 | $13,86433 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $385 | $5,28414 claims |
| Almatica Pharma LLCSertraline Hcl | $296 | $915134 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Ponte Vedra
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.